Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pegasus Biologics
Irvine, California, United Statespegasusbio.com ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Commercial
01
Overview
Pegasus Biologics developed and commercialized bioimplants such as OrthADAPT Bioimplant and Unite Biomatrix for soft tissue repair and wound care. Their products were used in orthopedics, sports medicine, neurosurgery, spine applications, and wound management. The company was acquired by Synovis Life Technologies in 2009.
- Therapeutic areas
- EndocrinologyRheumatology
- Modalities
- BioimplantCollagen scaffoldTissue scaffold
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on Pegasus Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pegasus Biologics.